The stock may react positively to margin expansion and EBITDA growth, but the continued revenue decline and lowered 2026 adjusted EBITDA guidance could cap upside. Watch for execution on commercial initiatives in H2 2026 and trends in delivery system placements, which remain weak. The high exposure to APAC (sales down 37.4% YoY) remains a risk.
Price Chart
Executive Summary
The Beauty Health Company (SKIN) reported full-year 2025 revenue of $300.8 million, down 10% YoY, driven by lower delivery systems sales. However, profitability improved significantly with adjusted EBITDA more than tripling to $45.1 million and gross margin expanding 1080 basis points to 65.3%. The company guided 2026 revenue to $285–$305 million and adjusted EBITDA to $35–$45 million, signaling continued margin recovery but modest top-line pressure.
Key Financial Metrics
Key Facts
- Full-year 2025 revenue was $300.8 million, down 10.0% from $334.3 million in 2024
- Adjusted EBITDA surged 266% YoY to $45.1 million (15.0% margin vs. 3.7% in 2024)
- Gross margin improved to 65.3% from 54.5% in 2024, driven by lower inventory charges and favorable consumables mix
- Delivery systems net sales dropped 29.8% YoY to $88.1 million; total units sold fell to 3,726 from 4,907
- Consumables net sales grew 1.8% to $212.7 million, now representing 70.7% of total revenue
- 2026 guidance: revenue $285–$305M (implying flat to -5.2% YoY), adjusted EBITDA $35–$45M (down 22% at midpoint)
- Cash balance declined to $233M from $370M due to convertible note repurchases
Financial Impact
Revenue declined by $33.5 million YoY, but cost discipline drove $134.1 million reduction in operating expenses and a 1080 bps gross margin expansion, resulting in $35.6 million improvement in adjusted EBITDA
Risk Factors
- Ongoing revenue decline, especially in delivery systems (-29.8% YoY)
- 2026 adjusted EBITDA guidance implies a decline from 2025 levels
- APAC region sales continue to weaken, down 37.4% YoY, likely due to China distributor transition
- Cash balance reduced by $137 million year-over-year despite profitability gains
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3255075 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Press Release | $11.10 | awaiting T+5 | — | $10.29 (−7.26%) |
Oct 14, 2026 13d ago | 8-K | $11.56 $11.03 | ▼ −4.58% | ▼ −5.04% | $10.29 (−10.99%) |
Oct 6, 2026 20d ago | 8-K | $0.5899 $11.56 | ▲ +1859.65% | ▲ +1860.63% | $10.29 (+1644.36%) |
Jul 21, 2026 14w ago | Press Release | $0.7616 | awaiting T+5 | — | $10.29 (+1251.10%) |
Jun 22, 2026 18w ago | 8-K | $0.6668 $0.7126 | ▲ +6.87% | ▲ +5.86% | $10.29 (+1443.19%) |
Apr 29, 2026 25w ago | Press Release | $0.8040 $0.8990 | ▲ +11.82% | ▲ +8.71% | $10.29 (+1179.85%) |
Apr 22, 2026 26w ago | 8-K | $0.8260 $0.8040 | ▼ −2.66% | ▼ −4.14% | $10.29 (+1145.76%) |
Mar 12, 2026 32w ago | Press Release | $1.27 $1.13 | ▼ −11.02% | ▼ −8.91% | $10.29 (+710.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers